LTZ Trademark

Trademark Overview


On Friday, October 14, 2022, a trademark application was filed for LTZ with the United States Patent and Trademark Office. The USPTO has given the LTZ trademark a serial number of 79360579. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2024. This trademark is owned by Shenzhen Zean Biomedical Co., Ltd.. The LTZ trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; drugs for medical purposes, namely, immunopotentiating drugs, immunosuppressive agents, medicines for tumor suppression; biochemical medicines for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; biological preparations for medical purposes for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; pharmaceutical preparations for treating cancers, neoplasms, autoimmune diseases, infectious diseases; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; immunostimulants; pre-filled syringes with pharmaceutical preparations for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases for medical purposes; injectable solutions in the nature of immunopotentiating drugs, immunosuppressive agents, medicines for tumor suppression for medical purposes; pharmaceutical...
ltz

General Information


Serial Number79360579
Word MarkLTZ
Filing DateFriday, October 14, 2022
Status700 - REGISTERED
Status DateTuesday, July 2, 2024
Registration Number7430993
Registration DateTuesday, July 2, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements


Description of MarkThe mark consists of wording "LTZ" and a stylized device. The device is composed of three group of lines, with each group consisting of three parallel lines, and each group of lines touching with an inner line of another group of lines at an approximately middle position, therefore forming a closed triangle.
Goods and ServicesMedicines for human purposes for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; drugs for medical purposes, namely, immunopotentiating drugs, immunosuppressive agents, medicines for tumor suppression; biochemical medicines for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; biological preparations for medical purposes for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases; pharmaceutical preparations for treating cancers, neoplasms, autoimmune diseases, infectious diseases; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; immunostimulants; pre-filled syringes with pharmaceutical preparations for the treatment of cancers, neoplasms, autoimmune diseases, infectious diseases for medical purposes; injectable solutions in the nature of immunopotentiating drugs, immunosuppressive agents, medicines for tumor suppression for medical purposes; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLTZ Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS

Party NameLTZ Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS

Party NameLTZ Therapeutics Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressUS

Party NameShenzhen Zean Biomedical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, January 19, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2023APPLICATION FILING RECEIPT MAILED
Sunday, March 19, 2023CHANGE OF OWNER RECEIVED FROM IB
Sunday, July 30, 2023ASSIGNED TO EXAMINER
Monday, July 31, 2023NON-FINAL ACTION WRITTEN
Tuesday, August 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 23, 2023NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, August 23, 2023NON-FINAL ACTION WRITTEN
Thursday, August 24, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 14, 2023REFUSAL PROCESSED BY MPU
Thursday, September 14, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 11, 2023REFUSAL PROCESSED BY IB
Saturday, February 17, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, March 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 27, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2024NOTIFICATION PROCESSED BY IB
Tuesday, April 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, July 8, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 2, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 17, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB